High serum phosphate and triglyceride levels in smoking women and men with CVD risk and type 2 diabetes

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Håglin, Lena M ^a   Törnkvist, Birgitta ^b   Bäckman, Lennart O ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Animal Health Care   (Sweden)

Author keywords

Gender; Glucose intolerance; Obesity; Phosphate; Risk factors; Smoking

Indexed keywords

CALCIUM; CHOLESTEROL; CREATININE; GLUCOSE; MAGNESIUM; PHOSPHATE; TRIACYLGLYCEROL; URATE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SMOKING; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84899063801     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-39     Document Type: Article

References (29)

1. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M, Am J Kidney Dis 2005 45 5 851 858 10.1053/j.ajkd.2005.01.005 15861350
2. Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. DeFronzo RA, Lang R, N Engl J Med 1980 303 22 1259 1263 10.1056/NEJM198011273032203 6999353
3. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A, Eur J Clin Nutr 2006 60 6 734 739 10.1038/sj.ejcn.1602375 16391583
4. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR, Rhee EJ, Oh KW, Lee WY, Park CY, Park SW, Kim SW, Diabetes Res Clin Pract 2009 83 1 119 125 10.1016/j.diabres.2008.08.018 19101054
5. Hypophosphataemia in the metabolic syndrome. Gender differences in body weight and blood glucose. Håglin L, Lindblad A, Bygren LO, Eur J Clin Nutr 2001 55 6 493 498 10.1038/sj.ejcn.1601209 11423926
6. Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis. Ditzel J, Lervang HH, Vasc Health Risk Manag 2010 6 829 836 20957128
7. Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients. Lippi G, Montagnana M, Salvagno GL, Targher G, Guidi GC, Diabetes Res Clin Pract 2009 84 1 3 e5 10.1016/j.diabres.2009.01. 003 19181413
8. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF, J Am Med Assoc 2011 305 11 1119 1127 10.1001/jama.2011.308
9. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS, Arch Intern Med 2007 167 9 879 885 10.1001/archinte.167.9.879 17502528
10. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF, Am J Kidney Dis 2009 54 4 619 637 10.1053/j.ajkd.2009.06.004 19692157
11. Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Ellam TJ, Chico TJ, Atherosclerosis 2012 220 2 310 318 10.1016/j.atherosclerosis.2011.09.002 21962238
12. Lervang HH Disturbance of inorganic phosphate metabolism in diabetes mellitus: its impact on the development of diabetic late complications. Ditzel J, Curr Diabetes Rev 2010 6 5 323 333 10.2174/157339910793360833 20701584
13. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Håglin L, Bäckman L, Törnkvist B, Cardiovasc Diabetol 2011 10 116 10.1186/1475-2840-10-116 22192330
14. Neter J, Wasserman W, Kutner MH, Applied Linear Regression Models Homewood Illinois: IRWIN 1983
15. Age, renal tubular phosphate reabsorption and serum phosphate levels in adults. Cirillo M, Ciacci C, De Santo NG, N Engl J Med 2008 359 8 864 866 10.1056/NEJMc0800696 18716307
16. Effects of smoking on severity of disease in primary hyperparathyroidism. Amstrup AK, Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L, Calcif Tissue Int 2010 87 5 406 413 10.1007/s00223-010-9416-6 20862465
17. Increased level of haemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Nilsson PM, Lind L, Pollare T, Berne C, Lithell HO, Metabolism 1995 44 5 557 561 10.1016/0026-0495(95)90110-8 7752901
18. Hyperphosphataemia is associated with the diabetes-related cardiovascular risk factors. Mahmud I, Rahman Z, Keka SI, Devnath S, Masum N, Hossain S, J Oleo Sci 2011 60 2 79 85 10.5650/jos.60.79 21263203
19. NaPi-IIa interacting proteins and regulation of renal reabsorption of phosphate. Hernando N, Gisler SM, Reining SC, Déliot N, Capuano P, Biber J, Murer H, Urol Res 2010 38 4 271 276 10.1007/s00240-010-0304-3 20665015
20. Smoking increases bone loss and decreases intestinal calcium absorption. Krall EA, Dawson-Hughes BJ, Bone Miner Res 1999 14 2 215 222 10.1359/jbmr.1999.14.2.215
21. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin resistant offspring of type 2 diabetic parents. Petersen KF, Dufour S, Shulman GJ, PLoS 2005 2 9 879 884
22. Smoking impairs muscle recovery from exercise. Price TH, Krishnan-Sarin S, Rothman DL, Am J Physiol Endocrinol Metab 2003 285 1 116 E122 12637259
23. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Paula FJ, Plens AE, Foss MC, Horm Metab Res 1998 30 5 281 284 10.1055/s-2007-978884 9660090
24. Impact of chronic cigarette smoking on body composition and fuel metabolism. Jensen EX, Fusch C, Jaeger P, Peheim E, Horber FF, J Clin Endocrinol Metab 1995 80 7 2181 2185 7608276
25. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Chiolero A, Faeh D, Paccaud F, Cornuz J, Am J Clin Nutr 2008 87 4 801 809 18400700
26. The metabolic syndrome as a link between smoking and cardiovascular disease. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M, Diabetes. Obes Metab 2004 6 2 127 132 10.1111/j.1462-8902.2004.00324.x 14746578
27. Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction. Dotevall A, Wilhelmsen L, Lappas G, Rosengren A, J Diabetes Complications 2005 19 1 26 34 10.1016/j.jdiacomp.2003. 10.001 15642487
28. Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Masulli M, Riccardi G, Galasso R, Vaccaro O, Nutr Metab Cardiovasc Dis 2006 16 5 364 370 10.1016/j.numecd.2005.06.005 16829345
29. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H, Kitamura A, Kiyama M, Sato S, Shimamoto T, Konishi M, Iso H, CIRCS Investigators, Diabetologia 2010 53 3 481 488 10.1007/s00125-009-1616-0 19946661